1. Home
  2. SRI vs IKT Comparison

SRI vs IKT Comparison

Compare SRI & IKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stoneridge Inc.

SRI

Stoneridge Inc.

HOLD

Current Price

$5.80

Market Cap

161.7M

ML Signal

HOLD

Logo Inhibikase Therapeutics Inc.

IKT

Inhibikase Therapeutics Inc.

HOLD

Current Price

$1.68

Market Cap

181.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SRI
IKT
Founded
1965
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
161.7M
181.9M
IPO Year
1997
2020

Fundamental Metrics

Financial Performance
Metric
SRI
IKT
Price
$5.80
$1.68
Analyst Decision
Buy
Buy
Analyst Count
1
2
Target Price
$16.00
$4.00
AVG Volume (30 Days)
136.2K
594.0K
Earning Date
11-05-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$874,357,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$7.68
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.54
$1.33
52 Week High
$9.10
$3.88

Technical Indicators

Market Signals
Indicator
SRI
IKT
Relative Strength Index (RSI) 43.30 65.77
Support Level $5.73 $1.52
Resistance Level $6.11 $1.67
Average True Range (ATR) 0.24 0.11
MACD 0.04 0.03
Stochastic Oscillator 18.92 97.14

Price Performance

Historical Comparison
SRI
IKT

About SRI Stoneridge Inc.

Stoneridge Inc is a manufacturer of electrical and electronic components used in automotive vehicles. The company produces instrumentation systems, vehicle management electronics, application-specific switches and actuators, sensors, security alarms, and vehicle tracking devices and monitoring services for commercial, automotive, off-highway, and agricultural vehicle markets. The company has three reportable segments: Control Devices, Electronics, and Stoneridge Brazil. It generates the majority of its revenue from the Electronics segment that produces driver information systems, camera-based vision systems, connectivity, and compliance products, and electronic control units. Its geographic segments include America, South America, Europe and Other.

About IKT Inhibikase Therapeutics Inc.

Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease (PD), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.

Share on Social Networks: